KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Intangibles (2016 - 2025)

Eli Lilly's Intangibles history spans 15 years, with the latest figure at $6.5 billion for Q4 2025.

  • For Q4 2025, Intangibles rose 5.76% year-over-year to $6.5 billion; the TTM value through Dec 2025 reached $6.5 billion, up 5.76%, while the annual FY2025 figure was $6.5 billion, 5.76% up from the prior year.
  • Intangibles reached $6.5 billion in Q4 2025 per LLY's latest filing, up from $6.4 billion in the prior quarter.
  • In the past five years, Intangibles ranged from a high of $8.1 billion in Q1 2021 to a low of $5.9 billion in Q2 2025.
  • Average Intangibles over 5 years is $7.0 billion, with a median of $6.9 billion recorded in 2023.
  • Peak YoY movement for Intangibles: soared 36197.27% in 2021, then dropped 11.09% in 2025.
  • A 5-year view of Intangibles shows it stood at $7.7 billion in 2021, then dropped by 6.31% to $7.2 billion in 2022, then fell by 4.16% to $6.9 billion in 2023, then dropped by 10.72% to $6.2 billion in 2024, then grew by 5.76% to $6.5 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Intangibles are $6.5 billion (Q4 2025), $6.4 billion (Q3 2025), and $5.9 billion (Q2 2025).